Trial Outcomes & Findings for Predicting Mortality in Patients With Return of Spontaneous Circulation After Cardiac Arrest (NCT NCT07020091)

NCT ID: NCT07020091

Last Updated: 2026-05-08

Results Overview

All-cause mortality within 30 days of ICU admission following ROSC.

Recruitment status

COMPLETED

Target enrollment

168 participants

Primary outcome timeframe

30 days after ICU admission

Results posted on

2026-05-08

Participant Flow

A total of 168 adult patients admitted to the intensive care unit after return of spontaneous circulation following cardiac arrest were included in this retrospective cohort study.

Eligible patients were identified retrospectively from institutional records and included in the analysis.

Participant milestones

Participant milestones
Measure
Overall Cohort
All adult patients admitted to the intensive care unit after return of spontaneous circulation following cardiac arrest.
Overall Study
STARTED
168
Overall Study
COMPLETED
168
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

All participants were included in the analysis; the sum of male and female participants equals the overall number.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Overall Cohort
n=168 Participants
All adult patients admitted to the intensive care unit after return of spontaneous circulation following cardiac arrest.
Age, Continuous
69.5 years
STANDARD_DEVIATION 16.2 • n=168 Participants
Sex: Female, Male
Female
77 Participants
n=168 Participants • All participants were included in the analysis; the sum of male and female participants equals the overall number.
Sex: Female, Male
Male
91 Participants
n=168 Participants • All participants were included in the analysis; the sum of male and female participants equals the overall number.
APACHE II score
24.3 score
STANDARD_DEVIATION 6.3 • n=168 Participants
SOFA score
8.6 score
STANDARD_DEVIATION 2.5 • n=168 Participants
SAPS 3 score
83.6 score
STANDARD_DEVIATION 16.4 • n=168 Participants
Charlson Comorbidity Index
5.5 score
STANDARD_DEVIATION 2.3 • n=168 Participants

PRIMARY outcome

Timeframe: 30 days after ICU admission

Population: All enrolled patients (n=168) were included in the analysis.

All-cause mortality within 30 days of ICU admission following ROSC.

Outcome measures

Outcome measures
Measure
Overall Cohort
n=168 Participants
All adult patients admitted to the intensive care unit after return of spontaneous circulation following cardiac arrest.
30-Day Mortality
112 participants

SECONDARY outcome

Timeframe: From ICU admission to hospital discharge (up to 60 days)

Population: All enrolled patients (n=168) were included in the analysis.

All-cause mortality recorded during the index hospital stay following return of spontaneous circulation (ROSC).

Outcome measures

Outcome measures
Measure
Overall Cohort
n=168 Participants
All adult patients admitted to the intensive care unit after return of spontaneous circulation following cardiac arrest.
In-Hospital Mortality
87 participants

SECONDARY outcome

Timeframe: 6 months after ICU admission

Population: All enrolled patients (n=168) were included in the analysis.

All-cause mortality assessed at 6 months following the initial cardiac arrest event. Mortality status is confirmed through hospital records and national death registry.

Outcome measures

Outcome measures
Measure
Overall Cohort
n=168 Participants
All adult patients admitted to the intensive care unit after return of spontaneous circulation following cardiac arrest.
6-Month Mortality
130 participants

Adverse Events

Overall Cohort

Serious events: 0 serious events
Other events: 0 other events
Deaths: 130 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Ahmet Duzgun, MD, Intensive Care Specialist

Department of Intensive Care, University of Health Sciences, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey

Phone: +90 544 674 5460

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place